Tamoxifen is currently first-line treatment for nearly all pre-menopausal women with hormone receptor-positive breast cancer.
In current medical practice, tamoxifen is the go-to treatment for nearly all pre-menopausal women diagnosed with hormone receptor-positive breast cancer.